Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...

The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex Pharmaceuticals. The drug, which is called suzetrigine and will be sold under ...

And the big headline here is that it’s not an opioid, and it’s non-addictive. So how does it work? Who should take it? Does it signal a new era for pain medication? Here to help break down this new ...

Many painkiller options already exist ... the motivations for constant attempts to produce new, non-opioid painkillers are largely either commercial — because opioid availability is limited ...

*The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx (suzetrigine), for adults with moderate to severe acute pain. Developed by ...

which would be the primary aim of developing a non-opioid painkiller. There already exist non-opioid painkillers, such as ibuprofen, paracetamol, and aspirin; however, they may not be appropriate ...

(MENAFN- The Conversation) A new non-opioid painkiller, suzetrigine , has just been approved by the US drug regulator, the FDA. It is the first non-opioid painkiller the agency has approved in ...

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

NEW ORLEANS — It's the first new type of painkiller in 20 years ... what you can expect from the new prescription medication. Opioid pain relievers come with many side effects, including ...

A new non-opioid painkiller, suzetrigine, has just been approved by the US drug regulator, the FDA. It is the first non-opioid painkiller the agency has approved in over two decades. Because of their ...